Table of Contents
1. Executive Summary
2. Industry Definition and Scope
3. Industry Overview
4. Global Macroeconomic Overview
5. Industry Trends
6. Industry Forecasts
7. Performance Gap
8. Conclusions
List of Figures
Chapter 3. Industry Overview
Figure 3.1: External forces shaping global diabetes drugs industry
Chapter 4. Global Macroeconomic Overview
Figure 4.1: Global GDP growth rate trend
Figure 4.2: Global inflation rate trend
Figure 4.3: Global population growth rate trend
Figure 4.4: Global unemployment rate trend
Figure 4.5: Regional GDP growth rate trend
Figure 4.6: Regional inflation rate trend
Figure 4.7: Regional population growth rate trend
Figure 4.8: Regional unemployment rate trend
Chapter 5. Industry Trends
Figure 5.1: Global diabetes drugs industry annual trend 2007-12 (US $B)
Figure 5.2: Global diabetes drugs industry regional trend 2007-12 (US $B)
Figure 5.3: Global diabetes drugs industry regional trend 2007-12 (%)
Figure 5.4: Global diabetes drugs industry segment trend 2007-12 (US $B)
Figure 5.5: Global diabetes drugs industry segment trend 2007-12 (%)
Figure 5.6: Global diabetes drugs industry quarterly trend 2010-11 (US $B)
Figure 5.7: Global diabetes drugs industry profitability trend 2007-12
Figure 5.8: Global diabetes drugs industry revenue per employee Trend 2007-12
Figure 5.9: Cost structure of global diabetes drugs industry 2007-12
Figure 5.10: Cost structure in North American diabetes drugs industry 2007-12
Figure 5.11: Cost structure in European diabetes drugs industry 2007-12
Figure 5.12: Cost structure in Asia Pacific diabetes drugs industry 2007-12
Figure 5.13: Top 5 companies vs. diabetes drugs industry gross profit & net profit analysis 2012
Figure 5.14: Cash on hand for global diabetes drugs industry 2007-12 (US $B)
Figure 5.15: Cash on hand for global diabetes drugs industry 2007-12 (%)
Figure 5.16: Asset for global diabetes drugs industry 2007-12 (US $B)
Figure 5.17: Assets for global diabetes drugs industry 2007-12 (%)
Figure 5.18: Debt for global diabetes drugs industry 2007-12 (US $B)
Figure 5.19: Debt for global diabetes drugs industry 2007-12 (%)
Figure 5.20: Industry shares of top players in global diabetes drugs industry in 2007
Figure 5.21: Industry shares of top players in global diabetes drugs industry in 2012
Figure 5.22: Global diabetes drugs industry 2007 market share analysis
Figure 5.23: Global diabetes drugs industry 2012 market share analysis
Chapter 6. Industry Forecasts
Figure 6.1: Global diabetes drugs industry annual forecast 2013-18 (US $B)
Figure 6.2: Global diabetes drugs industry quarterly forecast 2013-14 (US $B)
Figure 6.3: Global GDP growth rate forecast
Figure 6.4: Global inflation rate forecast
Figure 6.5: Global population growth rate forecast
Figure 6.6: Global unemployment rate forecast
Figure 6.7: Regional GDP growth rate forecast
Figure 6.8: Regional inflation rate forecast
Figure 6.9: Regional population growth rate forecast
Figure 6.10: Regional unemployment rate forecast
Figure 6.11: Global diabetes drugs industry regional forecast 2013-18 (US $B)
Figure 6.12: Global diabetes drugs industry regional forecast 2013-18 (%)
Figure 6.13: Global diabetes drugs industry segment forecast 2013-18 (US $B)
Figure 6.14: Global diabetes drugs industry segment forecast 2013-18 (%)
Chapter 7. Emerging Trends
Figure 7.1: Global diabetes drugs industry opportunity by region
Figure 7.2: Global diabetes drugs industry opportunity by segment
List of Tables
Chapter 3. Industry Overview
Table 3.1: Industry parameters of global diabetes drugs industry
Table 3.2: Relative industry attractiveness by region
Chapter 5. Industry Trends
Table 5.1: Regional revenue growth rate
Table 5.2: Segment revenue growth rate
Table 5.3: Percentage change in cost structure
Table 5.4: Percentage change in cash on hand
Table 5.5: Percentage change in total asset
Table 5.6: Percentage change in total debt
Table 5.7: Key companies by revenue growth
Table 5.8: Key companies by revenue decline
Chapter 6. Industry Forecasts
Table 6.1: Global diabetes drugs regional forecast growth rate
Table 6.2: Global diabetes drugs segment forecast growth rate